Katholieke Universiteit Leuven

University Hospital Antwerp

Katholieke Universiteit Leuven, K.u. Leuven Research & Development

Lieven Lagae

Berten Ceulemens

Berten Ceulemans

A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.

Growing community of inventors

Edegem, Belgium

Lieven Lagae